Lucentis (ranibizumab) is a prescription drug that’s used for eye conditions such as macular edema. Lucentis comes as a liquid solution that’s given by injection into the eye.

Ranibizumab, more commonly known by its brand name Lucentis, is delivered as an injection to the eye and runs about $2,023 per dose. Many patients require up to 12 injections per year. That's why ...

Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of ...

How does Lucentis work? Lucentis is given in the form of an injection which can be administered monthly or three times a month. The medicine helps to prevent new blood vessels growing, which can ...

Lucentis (ranibizumab) is a brand-name eye injection that’s prescribed for certain eye conditions in adults. As with other drugs, Lucentis can cause side effects, such as eye pain or irritation.

Lucentis is a prescription medication given by injection into the eye and it has side effects. Some Lucentis patients have had detached retinas and serious infections inside the eye.

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an ...

Potentially more important, Avastin is much cheaper than Lucentis -- costing about $50 per injection compared with $2,000 per injecton for Lucentis. Age-related macular degeneration is the leading ...

Lucentis is the trade name of the drug Ranibizumab, which can be useful for people with diabetes who are losing their sight from diabetic macular oedema or wet age related macular degeneration.